1887

Abstract

The performances of recombinant borrelial BBK32 proteins as antigens in the serology of erythema migrans (EM) were evaluated in an ELISA. Serum samples were obtained from 75 patients from different geographic areas where three borrelial species, , or , cause Lyme borreliosis. Antibodies to variant BBK32 proteins were compared with anti-flagella or with anti-IR peptide antibodies. In IgG ELISA at presentation of EM, 65/75 (87 %) patients had antibodies to one or more variants of BBK32, 29/75 (39 %) had antibodies to flagella and 29/75 (39 %) had antibodies to the VlsE IR peptide antigen. The immunoreactivity against variant BBK32 proteins differed in patients from different geographic regions. The present results suggest that the BBK32 proteins used in combination or in parallel may improve the laboratory diagnosis of EM.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.05095-0
2003-07-01
2019-11-16
Loading full text...

Full text loading...

/deliver/fulltext/jmm/52/7/JM520706.html?itemId=/content/journal/jmm/10.1099/jmm.0.05095-0&mimeType=html&fmt=ahah

References

  1. Aguero-Rosenfeld, M. E., Nowakowski, J., Bittker, S., Cooper, D., Nadelman, R. B. & Wormser, G. P. ( 1996;). Evolution of the serologic response to Borrelia burgdorferi in treated patients with culture-confirmed erythema migrans. J Clin Microbiol 34, 1–9.
    [Google Scholar]
  2. Fikrig, E., Feng, W., Barthold, S. W., Telford, S. R., III & Flavell, R. A. ( 2000;). Arthropod- and host-specific Borrelia burgdorferi bbk32 expression and the inhibition of spirochete transmission. J Immunol 164, 5344–5351.[CrossRef]
    [Google Scholar]
  3. Gomes-Solecki, M. J., Wormser, G. P., Persing, D. H., Berger, B. W., Glass, J. D., Yang, X. & Dattwyler, R. J. ( 2001;). A first-tier rapid assay for the serodiagnosis of Borrelia burgdorferi infection. Arch Intern Med 161, 2015–2020.[CrossRef]
    [Google Scholar]
  4. Heikkilä, T., Seppälä, I., Saxen, H., Panelius, J., Peltomaa, M., Julin, T., Carlsson, S.-A. & Lahdenne, P. ( 2002;). Recombinant BBK32 protein in serodiagnosis of early and late Lyme borreliosis. J Clin Microbiol 40, 1174–1180.[CrossRef]
    [Google Scholar]
  5. Huppertz, H.-I., Böhme, M., Standaert, S. M., Karch, H. & Plotkin, S. A. ( 1999;). Incidence of Lyme borreliosis in the Wurzburg region of Germany. Eur J Clin Microbiol Infect Dis 18, 697–703.[CrossRef]
    [Google Scholar]
  6. Junttila, J., Peltomaa, M., Soini, H., Marjamäki, M. & Viljanen, M. K. ( 1999;). Prevalence of Borrelia burgdorferi in Ixodes ricinus ticks in urban recreational areas of Helsinki. J Clin Microbiol 37, 1361–1365.
    [Google Scholar]
  7. Liang, F. T., Steere, A. C., Marques, A. R., Johnson, B. J. B., Miller, J. N. & Philipp, M. T. ( 1999;). Sensitive and specific serodiagnosis of Lyme disease by enzyme-linked immunosorbent assay with a peptide based on an immunodominant conserved region of Borrelia burgdorferi VlsE. J Clin Microbiol 37, 3990–3996.
    [Google Scholar]
  8. Mitchell, P. D., Reed, K. D., Aspeslet, T. L., Vandermause, M. F. & Meslki, J. W. ( 1994;). Comparison of four immunoserologic assays for detection of antibodies to Borrelia burgdorferi in patients with culture-positive erythema migrans. J Clin Microbiol 32, 1958–1962.
    [Google Scholar]
  9. Nowakowski, J., Schwartz, I., Liveris, D. & 7 other authors ( 2001;). Laboratory diagnostic techniques for patients with early erythema migrans: a comparison of different techniques. Clin Infect Dis 33, 2023–2027.[CrossRef]
    [Google Scholar]
  10. Oksi, J., Marttila, H., Soini, H., Aho, H., Uksila, J. & Viljanen, M. K. ( 2001;). Early dissemination of Borrelia burgdorferi without generalized symptoms in patients with erythema migrans. APMIS 109, 581–588.[CrossRef]
    [Google Scholar]
  11. Seppälä, I. J. T., Kroneld, R., Schauman, K., Forsen, K. O. & Lassenius, R. ( 1994;). Diagnosis of Lyme borreliosis: non-specific serological reactions with Borrelia burgdorferi sonicate antigen caused by IgG2 antibodies. J Med Microbiol 40, 293–302.[CrossRef]
    [Google Scholar]
  12. Smith, R. P., Schoen, R. T., Rahn, D. W., Sikand, V. K., Nowakowski, J., Parenti, D. L., Holman, M. S., Persing, D. H. & Steere, A. C. ( 2002;). Clinical characteristics and treatment outcome of early Lyme disease in patients with microbiologically confirmed erythema migrans. Ann Intern Med 136, 421–428.[CrossRef]
    [Google Scholar]
  13. Steere, A. C. ( 2001;). Lyme disease. N Engl J Med 345, 115–125.[CrossRef]
    [Google Scholar]
  14. Strle, F., Nelson, J. A., Ruzic-Sabljic, E. & 7 other authors ( 1996;). European Lyme borreliosis; 231 culture-confirmed cases involving patients with erythema migrans. Clin Infect Dis 23, 61–65.[CrossRef]
    [Google Scholar]
  15. Vaz, A., Glickstein, L., Field, J. A., McHugh, G., Sikand, V. K., Damle, N. & Steere, A. C. ( 2001;). Cellular and humoral immune responses to Borrelia burgdorferi antigens in patients with culture-positive early Lyme disease. Infect Immun 69, 7437–7444.[CrossRef]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.05095-0
Loading
/content/journal/jmm/10.1099/jmm.0.05095-0
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error